NEW YORK (GenomeWeb) – Almac Diagnostics and OncoMed Pharmaceuticals will develop a companion diagnostic test to predict patient response to a new therapeutic under development by OncoMed. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.